Ultimovacs ASA (ULTI) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.299x

Based on the latest financial reports, Ultimovacs ASA (ULTI) has a cash flow conversion efficiency ratio of -0.299x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.70 Million ≈ $-2.60 Million USD) by net assets (Nkr82.67 Million ≈ $8.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ultimovacs ASA - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Ultimovacs ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ultimovacs ASA total liabilities for a breakdown of total debt and financial obligations.

Ultimovacs ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ultimovacs ASA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
INFOvine co. Ltd KQ:115310	0.021x
Sajo Oyang KO:006090	0.010x
Accelerate Property Fund Ltd JSE:APF	0.025x
Big Sunshine Co Ltd TW:1475	0.122x
Silvano Fashion Group AS WAR:SFG	0.016x
Societe de Tayninh SA PA:TAYN	0.000x
Ozerden Plastik Sanayi IS:OZRDN	0.718x
Fluence Corporation Limited F:4SVE	0.638x

Annual Cash Flow Conversion Efficiency for Ultimovacs ASA (2016–2024)

The table below shows the annual cash flow conversion efficiency of Ultimovacs ASA from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see ULTI market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr82.67 Million ≈ $8.70 Million	Nkr-163.40 Million ≈ $-17.19 Million	-1.977x	-190.92%
2023-12-31	Nkr279.39 Million ≈ $29.40 Million	Nkr-189.83 Million ≈ $-19.98 Million	-0.679x	-82.06%
2022-12-31	Nkr449.35 Million ≈ $47.28 Million	Nkr-167.69 Million ≈ $-17.65 Million	-0.373x	-75.92%
2021-12-31	Nkr593.15 Million ≈ $62.42 Million	Nkr-125.83 Million ≈ $-13.24 Million	-0.212x	+4.27%
2020-12-31	Nkr488.38 Million ≈ $51.39 Million	Nkr-108.22 Million ≈ $-11.39 Million	-0.222x	-56.42%
2019-12-31	Nkr444.63 Million ≈ $46.79 Million	Nkr-62.99 Million ≈ $-6.63 Million	-0.142x	+55.04%
2018-12-31	Nkr159.90 Million ≈ $16.83 Million	Nkr-50.39 Million ≈ $-5.30 Million	-0.315x	-92.70%
2017-12-31	Nkr166.48 Million ≈ $17.52 Million	Nkr-27.23 Million ≈ $-2.86 Million	-0.164x	+60.13%
2016-12-31	Nkr75.82 Million ≈ $7.98 Million	Nkr-31.10 Million ≈ $-3.27 Million	-0.410x	--

About Ultimovacs ASA

OL:ULTI Norway Biotechnology

Market Cap

$52.14 Million

Nkr495.45 Million NOK

Market Cap Rank

#21811 Global

#196 in Norway

Share Price

Nkr14.40

Change (1 day)

+0.00%

52-Week Range

Nkr14.40 - Nkr14.40

All Time High

Nkr162.00